Company: SMNR
Filing Date: 2025-12-03
Form Type: S-8
Source: 0001193125-25-306962
Chunk: 6

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-12-03
Form: S-8
Chunk 6
---
 www.sec.gov. We also maintain a website at www.semnurpharma.com. Through our website, we make available, free of charge, annual, quarterly and current reports, prospectus and other information as soon as reasonably practicable after they are electronically filed with, or furnished to, the Commission. The information contained on, or that may be accessed through, our website is not part of, and is not incorporated into, this Reoffer Prospectus. INCORPORATION OF CERTAIN INFORMATION BY REFERENCE The following documents, which have been filed by the Company with the Commission, are hereby incorporated by reference into this Registration Statement of which this Reoffer Prospectus forms a part by reference:

| (a) | The Registrant’s prospectus filed with the Commission under Rule 424(b)(3) of the Securities Act on August 13, 2025; |

| (d) | The description of the Registrant’s Common Stock contained in Exhibit 4.1 to the Registrant’s                                                                                    
 Current Report on Form 8-K filed with the Commission on December                                                                                                                 
 3, 2025, which updates the description of the Registrant’s Common Stock contained in the Registration Statement on Form 8-A                                                      
 (File No. 001-41351) filed with the Commission on April 6, 2022, pursuant to Section 12(b) of the Exchange Act, and any amendments or reports filed for the purpose of updating, 
 amending, or otherwise modifying such description.                                                                                                                               |

1

All other reports and other documents subsequently filed by the Registrant pursuant to
Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be
deemed to be incorporated by reference into this Registration Statement and to be a part of this Registration Statement from the date of the filing of such reports and documents, except as to any portion of any future annual or quarterly report to
stockholders or document or current report furnished under Items 2.02 or 7.01 of Form 8-K that is not deemed filed under such provisions.

For the purposes of this Registration Statement, any statement contained in a document incorporated or deemed to be incorporated by reference
herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document that also